Tinidazole: Another Therapeutic Option for Syphilis?


Journal

Journal of clinical pharmacology
ISSN: 1552-4604
Titre abrégé: J Clin Pharmacol
Pays: England
ID NLM: 0366372

Informations de publication

Date de publication:
09 2020
Historique:
received: 20 01 2020
accepted: 31 03 2020
pubmed: 15 5 2020
medline: 1 7 2021
entrez: 15 5 2020
Statut: ppublish

Résumé

After the incidental observation of an almost complete resolution of maculopapular eruption in a patient having simultaneously secondary syphilis and trichomonas vaginalis infection, we extended the treatment with tinidazole (500 mg 4 times daily for 7 days) to 10 other early syphilis patients before the start of the conventional penicillin treatment. All patients showed marked improvement of their lesions in a few days. After the introduction of the conventional penicillin regimen, the lesions further improved and VDRL titers declined at least 4-fold within 6 months in all patients. Tinidazole is a 5-nitroimidazole derivative as well as metronidazole but with a longer plasma half-life. It is activated intracellularly by bacterial/parasitic enzymes to a redox cytotoxic intermediate that damages large protein molecules and inhibits repair and transcription of DNA affecting also the cell wall. With this action, tinidazole might also have a synergic action with penicillin and doxycycline, facilitating the entry of such drugs. It is possible that tinidazole has the same bactericidal action on spirochetes other than Borrelia, such as Treponema pallidum, explaining its rapid therapeutic action on the lesions of early syphilis. Whether this action could be confirmed by studies on larger series of patients, tinidazole might be considered in case of allergy to penicillin or other antibiotics usually prescribed in syphilis.

Identifiants

pubmed: 32408379
doi: 10.1002/jcph.1629
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antitrichomonal Agents 0
Tinidazole 033KF7V46H
Penicillin G Benzathine RIT82F58GK

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1185-1188

Informations de copyright

© 2020, The American College of Clinical Pharmacology.

Références

Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997;337(5):307-314.
Pound MW, May DB. Proposed mechanism and preventative options of Jarish-Herxheimer reactions. J Clin Pharm Ther 2005;30(3):291-295.
Sapi E, Kaur N, Anyanwu S, et al. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist. 2011; 4:97-113.
Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole. Int Microbiol. 2004;7:139-142.
Wood BA, Faulkner JK, Monro AM. The pharmacokinetics, metabolism and tissue distribution of tinidazole. J Antimicrob Chemother. 1982;10(suppl A):43-45.
Klimowicz A, Nowak A, Bielecka-Grzela S. Penetration of tinidazole into skin blister fluid following its oral administration. Eur J Clin Pharmacol. 1992;43(5):523-526.
Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS. Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy. Drugs. 1982; 24(2):85-117.
Mattila J, Männistö PT, Mäntylä R, Nykänen S, Lamminsivu U. Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother. 1983;23(5):721-725.
Edwards DI. Mechanism of antimicrobial action of metronidazole. J Antimicrob Chemother. 1979; 5(5):499-450
Bergan T, Fotland MH. In vitro interactions between metronidazole or tinidazole, doxycycline and co-trimoxazole on the effect against anaerobic bacteria. Scand J Gastroenterol Suppl. 1984;91:95-101.
Davies AH, McFadzean JA. Squires A. Treatment of Vincent's stomatitis with metronidazole. Br Med J. 1964;1(5391):1149-50.
Davies AH. Metronidazole in human infections with syphilis. Br J Vener Dis. 1967;43(3):197-200.
Wilkinson AE, Rodin P, McFadzean JA, Squires S. A note on the effect of metronidazole on the Nichols strain of Treponema pallidum in vitro and in vivo. Br J Vener Dis. 1967;43(3):201-203.

Auteurs

Francesco Drago (F)

Dermatology Clinic, Ospedale Policlinico San Martino, Genoa, Italy.

Giulia Ciccarese (G)

Dermatology Clinic, Ospedale Policlinico San Martino, Genoa, Italy.

Alfredo Rebora (A)

DI.S.Sal., Section of Dermatology, University of Genoa, Genoa, Italy.

Aurora Parodi (A)

DI.S.Sal., Section of Dermatology, University of Genoa, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH